CREDIT SUISSE AG/ - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 72 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$9,417
-24.0%
10,500
-0.0%
0.00%
Q4 2022$12,392
-84.7%
10,502
-2.2%
0.00%
Q3 2022$81,000
+22.7%
10,737
+1.8%
0.00%
Q2 2022$66,000
-96.1%
10,545
-92.4%
0.00%
-100.0%
Q4 2020$1,702,000
+62.2%
138,481
+7.4%
0.00%0.0%
Q3 2020$1,049,000
-16.5%
128,952
-1.4%
0.00%0.0%
Q2 2020$1,256,000
+63.5%
130,803
+15.8%
0.00%0.0%
Q1 2020$768,000
-45.5%
112,999
+19.5%
0.00%0.0%
Q4 2019$1,409,000
+1.4%
94,561
-30.3%
0.00%0.0%
Q3 2019$1,390,000135,5970.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders